03:06:54 Europe / Stockholm

Kurs & Likviditet

Kursutveckling och likviditet under dagen för detta pressmeddelande

Beskrivning

LandNorge
ListaMERK Equities
SektorHälsovård
IndustriBioteknik
EXACT Therapeutics är verksamma inom medicinteknik. Bolaget är specialiserade inom utveckling av medicintekniska produkter. Produktportföljen är bred och inkluderar exempelvis tekniska plattformar för läkemedelstestning. Utöver huvudverksamheten erbjuds även tillhörande kringtjänster och mervärdesprodukter. Verksamheten drivs globalt med störst närvaro inom den nordiska marknaden. Bolaget gick tidigare under namnet Phoenix Solutions och har idag sitt huvudkontor i Oslo.

Kalender

2021-08-25 Kvartalsrapport 2021-Q2
2021-06-01 Årsstämma 2021
2021-05-14 Ordinarie utdelning EXTX 0.00 NOK
2021-04-29 Bokslutskommuniké 2020
2020-07-27 Split EXTX 1:250
2020-07-24 Extra Bolagsstämma 2020
2020-10-28 16:00:00
CFO for hire AS, a company fully owned by Stig Jarle Pettersen, CFO of EXACT
Therapeutics AS, has on 23 October 2020 transferred 12,000 shares from its VPS
account to the VPS account of Dr. Jean Michel Cossery, Board member of EXACT
Therapeutics AS. 
The background for this transaction is that Jean Michel Cossery did not have a
VPS account at the time of the listing of EXACT Therapeutics, a requirement of
the Merkur market. Consequently, the shares were held by CFO for hire AS until a
VPS account for Jean Michel Cossery was established. 
Following this transaction, Jean Michel Cossery SAS has 12,000 shares in EXACT
Therapeutics AS and CFO for hire AS has 30,000 shares in EXACT Therapeutics AS. 

About EXACT EXACT-Tx is a clinical stage Anglo-Norwegian biotech company
developing a technology platform for targeted therapeutic enhancement – Acoustic
Cluster Therapy (ACT®). ACT® sonoporation is a unique approach to
ultrasound-mediated, targeted drug enhancement – with the potential to
significantly amplify the clinical utility of a wide range of therapeutic agents
across a multitude of indications including within oncology (chemotherapy,
immunotherapy), infectious diseases, and neurological conditions. 

www.exact-tx.com 

For more information contact: 
Dr Rafiq Hasan, CEO of EXACT-Therapeutics 
Rafiq@exact-tx-com 

Richard Hayhurst/Janet Joy 
Tel +44 7711 821527 
richard@rhapr.eu